ns 2028 has been researched along with adenosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Busse, R; Fleming, I; Randriamboavonjy, V; Schrader, J | 1 |
2 other study(ies) available for ns 2028 and adenosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway.
Topics: Adenosine; Adenosine Triphosphate; Blood Platelets; Carbazoles; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Humans; In Vitro Techniques; Indoles; Insulin; Nitric Oxide; Oxadiazoles; Oxazines; Protein Kinase Inhibitors; Serotonin; Vasodilation | 2004 |